Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists-Reference-Cited by-同舟云学术

Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists

Published:2007-12 Issue:1-3 Volume:577 Page:78-86
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Sundqvist Monika,Kristensson Elin,Adolfsson Rebecka,Leffler Agnes,Ahlstedt Ingela,Engberg Susanna,Drmota Tomas,Sigfridsson Kalle,Jussila Rainer,de Verdier Jennie,Novén Anna,Johansson Anders,Påhlman Ingrid,von Mentzer Bengt,Lindström Erik

Publisher

Elsevier BV

Subject

Pharmacology

Reference45 articles.

1. Neurokinin A (NK2) receptor revisited with SR48968, a potent non-peptide antagonist;Advenier;Biochem. Biophys. Res. Commun.,1992

2. Antagonists that demonstrate species differences in neurokinin-1 receptors;Appell;Mol. Pharmacol.,1992

3. Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist;Ballard;Eur. J. Pharmacol.,2001

4. Different subtypes of tachykinin NK1 receptor binding sites are present in the rat brain;Beaujouan;J. Neurochem.,2000

5. Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345;Beresford;Br. J. Pharmacol.,1991

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ionic signalling mechanisms involved in neurokinin‐3 receptor‐mediated augmentation of fear‐potentiated startle response in the basolateral amygdala;The Journal of Physiology;2022-09-13

2. The Neurokinins: Peptidomimetic Ligand Design and Therapeutic Applications;Current Medicinal Chemistry;2020-03-27

3. Pharmacological Properties of FK886, a New, Centrally Active Neurokinin-1 Receptor Antagonist;Biological and Pharmaceutical Bulletin;2013

4. Evaluation of exposure properties after injection of nanosuspensions and microsuspenions into the intraperitoneal space in rats;Drug Development and Industrial Pharmacy;2012-12-17

5. Neurokinin 3 (NK3) Receptor Modulators for the Treatment of Psychiatric Disorders;Frontiers in CNS Drug Discovery;2012-03-26